Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Dermatologic 1Breast 1

Conditions

Stomach Neoplasms 2Colonic Neoplasms 2Colonic Polyps 1Breast Neoplasms 1

Interventions

Oxaliplatin 1435Fluorouracil 1316Capecitabine 1112Gemcitabine 1054Leucovorin 935Bevacizumab 845Irinotecan 827Cisplatin 673Radiotherapy 559Cetuximab 481pembrolizumab 435Paclitaxel 400Drug Therapy 358Nivolumab 349130-nm albumin-bound paclitaxel 326Docetaxel 289Sorafenib 288S 1 (combination) 278Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 256lenvatinib 222sintilimab 218tislelizumab 213durvalumab 211regorafenib 208Radiosurgery 204Magnetic Resonance Spectroscopy 203apatinib 202Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Menthol × Gastrointestinal × Clear all
NCT01855607 2024-07-11

Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Columbia University

Phase 2 Terminated
12 enrolled 5 charts
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT02588248 2022-04-19

MINT-C

University Hospitals Cleveland Medical Center

Phase 3 Terminated
82 enrolled 10 charts
Gastrointestinal

Colonic Neoplasms, Colonic Polyps

NCT01411176 2012-06-29

Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Nihon Pharmaceutical Co., Ltd

Phase 3 Completed
85 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01411189 2012-06-29

Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Nihon Pharmaceutical Co., Ltd

Phase 3 Completed
33 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡